Dr. Klaus Moosmayer has been Chief Ethics, Risk and Compliance Officer of Novartis since December 1, 2018. He is a member of the Executive Committee of Novartis.
Klaus previously was Chief Compliance Officer of Siemens AG, a position he held since 2014. During his 18-year career at Siemens, he also served as Chief Counsel Compliance, Compliance Operating Officer and Corporate Legal Counsel. Before joining Siemens, Klaus practiced law in Germany, specializing in white-collar crime, litigation and business law.
Klaus is Chair of the Anti-Corruption Task Force of the Business and Industry Advisory Committee at the Organization for Economic Co-operation and Development (OECD); co-founder and Chair of the European Chief Compliance and Integrity Officers’ Forum; and was serving as Chair of the B20 Integrity & Compliance Task Force under the G20 presidency of Germany and subsequently as Co-Chair of the Taskforce under the G20 presidency of Argentina. He lectures Compliance at the University of St. Gallen and the International Anti-Corruption Academy in Vienna and publishes and speaks extensively about Compliance and Risk topics on national and international level.